ADAli Nail Demir

Ali Nail Demir

*This is an algorithmically generated author record based on publicly available information.

Ali Nail Demir has a total of 163 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Associations of Atherogenic Lipid Ratios and Visceral Adiposity Indices with Cardiovascular Risk Scores in Rheumatoid Arthritis

    by Uğur Güngör Demir, Ali Nail Demir, Alper Uysal

    Background/Aims: Rheumatoid arthritis (RA) is associated with increased cardiovascular risk beyond traditional risk factors. Recently, atherogenic lipid ratios and visceral adiposity indices have emerged as potential markers of cardiometabolic risk in chronic inflammatory diseases. This study aimed to examine their associations with estimated cardiovascular risk scores in patients with RA. Materials and Methods: This cross-sectional study included 198 patients with RA. Individuals with established cardiovascular disease or majör comorbid conditions were excluded. Atherogenic lipid ratios, including the Atherogenic Index of Plasma (AIP), Atherogenic Coefficient (AC), Castelli Risk Index (CRI)-1, CRI-2, and triglycerides (TG)/high-density lipoprotein cholesterol (HDL-C) ratio, were calculated. Visceral adiposity indices included the Visceral Adiposity Index (VAI), Lipid Accumulation Product (LAP), and Waist-Triglyceride Index. Ten-year cardiovascular risk was estimated using the modified Framingham Risk Score (FRS) and the modified Systematic Coronary Risk Evaluation (SCORE) system. Results: Atherogenic lipid ratios, particularly AC, CRI-1, and CRI-2, demonstrated weak but statistically significant positive correlations with both modified SCORE and modified FRS. In contrast, adiposity-related indices (LAP and VAI) and atherogenic lipid ratios (AIP and the TG/HDL-C ratio) were significantly associated with the modified FRS but not with the modified SCORE. No significant associations were observed between RA disease activity measures and cardiovascular risk scores. Conclusion: In RA, cardiovascular risk is linked closely to adiposity and lipid disturbances than current disease activity. Modified FRS may better capture adiposity-related cardiovascular risk than modified SCORE, and incorporation of atherogenic lipid and visceral adiposity indices may improve risk stratification. Cite this article as: Demir UG, Demir AN, Uysal A. Associations of atherogenic lipid ratios and visceral adiposity indices with cardiovascular risk scores in rheumatoid arthritis. ArchRheumatol. Published online May 11, 2026. doi: 10.5152/ArchRheumatol.2026.26338.

  • Dual perspectives on large language models in rheumatology: physician-rated quality and patient-centered usability of GPT-4o versus DeepSeek-V3

    by Bulent Akyuz, Ilhan Sezer, Ali Nail Demir, Cahit Kacar

    Over the past two decades, biologic disease-modifying antirheumatic drugs (bDMARDs), which play a key role in symptom control, prevention of flares, and slowing structural damage, have become a cor...

  • Open Access

    Evaluation of the Diagnostic Performance of ChatGPT in Radiographic Staging of Sacroiliitis According to the Modified New York Criteria

    by Uğur Güngör Demir, Ali Nail Demir, Alper Uysal

    Background/Aims: This study aimed to evaluate the diagnostic performance of ChatGPT in grading sacroiliitis on pelvic radiographs according to the modified New York criteria. Materials and Methods: This retrospective study included 266 individuals with or without radiographic sacroiliac joint involvement according to the modified New York criteria (231 with ankylosing spondylitis and 35 without radiographic evidence of sacroiliitis). Two experts independently graded all radiographs based on the modified New York criteria, with disagreements resolved by a third reviewer. ChatGPT-5o (OpenAI, 2025) was prompted to classify each radiograph using a standardized English-language instruction. ChatGPT’s grading outputs were compared with expert consensus. Results: A statistically significant association was found between ChatGPT and expert gradings, but agreement remained slight (κ = 0.136). Multi-class performance was limited (overall accuracy = 30%), while binary analysis showed higher apparent accuracy (78%) due to a strong positive bias. Sensitivity was 0.796, specificity was 0.696, positive predictive value was 0.946, and negative predictive value was 0.338. Per-grade area under curve values ranged from 0.52 to 0.75, with the highest for Grade 0. Conclusion: ChatGPT demonstrated only limited agreement with expert assessments and showed poor ability to distinguish between sacroiliitis stages, performing adequately only for normal joints. These findings suggest that large language models like ChatGPT are unsuitable for direct radiographic interpretation without integration into specialized, vision-based diagnostic frameworks. Cite this article as: Güngör Demir U, Demir AN, Uysal A. Evaluation of the diagnostic performance of ChatGPT in radiographic staging of sacroiliitis according to the modified New York criteria. ArchRheumatol. 2026;41(1):57-63.

  • Open Access

    Evaluation of remission in patients with radiographic axial spondyloarthritis using an ultrasonography-based enthesitis score: a cross-sectional study

    by Emrah Koç, Burak Okyar, Sibel Bakırcı, Suade Özlem Badak, Ali Nail Demir, İsMail Uçar, Gökhan Sargın, Servet Yüce, Emine Duygu Ersözlü

    Introduction: This study aimed to evaluate ultrasonographic entheseal abnormalities in patients with radiographic axial spondyloarthritis (r-axSpA) who were in clinical remission for at least 6 months and receiving either nonsteroidal anti-inflammatory drugs (NSAIDs) or biologic agents. Material and methods: Seventy-two r-axSpA patients were included, divided into NSAID users (n = 23) and biologic agent users (n = 49). Demographic and clinical data were recorded. Ultrasound assessment was performed bilaterally at 10 entheseal sites using a 7–13 MHz linear probe. Elementary lesions defined by OMERACT – hypoechogenicity, thickening, power Doppler (PD) signal, calcification, enthesophyte, and bone erosion – were evaluated and scored on a scale of 0–3. Inflammation scores included hypoechogenicity, thickening, and PD signal; chronicity scores included bone erosion, enthesophyte, and calcification. Results: A total of 720 entheseal sites were analyzed. The quadriceps tendon was the most frequently affected site (98.6%), followed by the distal patellar tendon (94.4%), Achilles tendon (70.8%), and plantar fascia (70.8%). Hypoechogenicity, thickening, enthesophyte formation, and bone erosion were the most common abnormalities, while PD signals and calcifications were rare. Nonsteroidal anti-inflammatory drug users showed significantly higher C-reactive protein (CRP) (0.62 ±0.53 vs. 0.41 ±0.27 mg/dl, p = 0.027) and erythrocyte sedimentation rate (ESR) levels (11.91 ±7.72 vs. 7.65 ±5.66 mm/h, p = 0.010) than biologic users, despite similar Axial Spondyloarthritis Disease Acti­vity Score with CRP score. Mean inflammation, tissue damage, and total ultrasound (US) enthesitis scores were 4.85 ±4.37, 6.44 ±4.44, and 11.24 ±8.21, respectively, with no significant difference between treatment groups. Seven biologic-treated, overweight, or obese patients had markedly elevated total US scores (30.43 ±5.83), suggesting persistent entheseal inflammation and structural damage. Conclusions: Ultrasound-based enthesitis scoring may reveal subclinical disease activity in r-axSpA patients in remission, highlighting the added value of integrating musculoskeletal US into disease monitoring.

  • Open Access

    IMPACT OF VARIOUS RHEUMATOID ARTHRITIS TREATMENTS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN

    by Alper Uysal, Ali Nail Demir, Uğur Güngör Demir

    Aim:The objective of this study was to evaluate the impact of various treatment options on bone mineral density (BMD) in postmenopausal women with rheumatoid arthritis (RA). Material and Methods:A retrospective analysis was conducted on the data of 163 postmenopausal women, including 121 RA patients meeting the 2010 American College of Rheumatology/European League Against Rheumatism criteria and 42 healthy controls. RA patients were categorized into four groups based on their treatment regimens: Group 1, receiving conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) alone; Group 2, receiving csDMARDs in combination with glucocorticosteroids (GCs); Group 3, receiving csDMARDs with GCs and biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs); and Group 4, receiving b/tsDMARDs combined with methotrexate. Data collected included demographic information, BMD T-scores at lumbar spine (L1-L4), femoral neck, total hip, and serum calcium, and vitamin D levels. Results:RA patients had significantly lower BMD T-scores at L1-L4, femoral neck, and total hip compared to controls (p=0.041, p=0.026, and p=0.003, respectively). Among treatment groups, patients receiving csDMARDs with GCs exhibited greater bone loss, particularly in femoral neck scores, compared to other regimens (all p≤0.005). Conversely, b/tsDMARDs showed a protective effect on BMD, mitigating bone loss despite the use of low-dose GCs. Conclusion:This study demonstrates that RA treatments significantly influence BMD in postmenopausal women. b/tsDMARDs appear to mitigate the adverse effects of GCs on bone health, while prolonged GC use is associated with greater bone loss, especially in the csDMARDs group.


  • Relationship between knee osteoarthritis severity and novel peripheral inflammatory markers

    by Alper Uysal, Uğur Güngör Demir, Ali Nail Demir, Hacer Paksoy Karateke

    Aim Osteoarthritis (OA) is a degenerative joint disease influenced by inflammatory processes. This study aimed to investigate the relationship between inflammatory markers and OA severity. Methods This retrospective study included patients aged ≥40 with knee OA, classified using the Kellgren–Lawrence (KL) grading system. Data from 167 individuals were divided into three groups: Group 1 included 50 healthy individuals (KL grade 0), Group 2 comprised 56 with mild OA (KL grades 1–2), and Group 3 included 61 with severe OA (KL grades 3–4). Peripheral inflammation was assessed through hemogram-derived parameters, including platelet-tolymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-neutrophil ratio (PNR), neutrophil-lymphocyteplatelet ratio (NLPR), systemic immune response index (SIRI), systemic immune inflammation index (SII), and systemic inflammation aggregate index (SIAI). Results Demographic characteristics were similar across groups (p > 0.05). Neutrophil count, monocyte count, NLR, LMR, PNR, NLPR, SII, SIRI, and SIAI showed significant differences (p<0.05). PNR and SIRI values differed significantly among the three groups across all pairwise comparisons. SIRI exhibited a weak positive correlation with KL grades (r = 0.240, p=0.009), while PNR showed a weak negative correlation (r = -0.273, p=0.003). ROC (Receiver Operating Characteristic) analysis showed moderate discriminatory power for SIRI and PNR with AUCs (Area Under the Curve) of 0.762 and 0.740, respectively. Conclusion This study indicates a potential link between OA and systemic inflammation. SIRI and PNR may be useful markers for assessing OA severity.


  • Open Access

    Romatolojide Güncel Tedaviler

    by Duygu Kurtuluş, Ali Nail Demir, İsMail Uçar, Önay Gerçik, Hüseyin Ali Öztürk, Alper Yıldırım, Neslihan Gökçen, Zeynep Kaya, Meryem Can, Zübeyde Uğurlu, et al.

    Analjezikler, Non-Steroid Anti-İNFLAMATUAR İlaçlar ve Kortikosteroidler Duygu KURTULUŞ Biyolojik Olmayan Hastalık Modifiye Edici Antiromatizmal ilaçlar Ali Nail DEMİR Romatolojide Biyolojik Tedavi Ajanları İsmail UÇAR İmmunsupresifler ve Diğer İlaçlar Önay GERÇİK Romatolojide İntravenöz İmmünoglobulin Uygulamaları Hüseyin Ali ÖZTÜRKAlper YILDIRIM Romatolojide Plazmaferez Uygulamaları Alper YILDIRIM Erken Artrit ve Palindromik Romatizma: Güncel Tedavi Neslihan GÖKÇEN Romatoid Artrit: Güncel Tedavi Zeynep KAYA Meryem CAN Romatoid Artritte Ekstra-Artiküler Tutulum Tedavisi Zübeyde UĞURLU Atalay DOĞRU Tekrarlayıcı Seronegatif Pİtting Ödemli Simetrik Sinovit (R3SPE) Sendromu Tedavi Yönetimi Berkan ARMAĞAN Erişkin Başlangıçlı Still Hastalığına Güncel Yaklaşım Ahmet KOR Şükran ERTEN Enfeksiyöz Artritler: Bakteriyel Artritler, Lyme Artriti, Viral Artritler, Mikobakteriyel, Brucella, Fungal Ve Parazitik Artritler: Güncel Tedavi Fatma TUNCER KURU Ankilozan Spondilit ve Non-Radyografik Aksiyel Spondiloartrit: Güncel Tedavi Dilek SOLMAZ Periferik Spondiloartrit: Güncel Tedavi Fatih SARITAŞ Psöriatik Artrit: Güncel Tedavi Selda ÇELİK Enteropatik Artrit Tedavisi Mete PEKDİKER Reaktif Artrit: Güncel Tedavi Özgül SOYSAL GÜNDÜZ Jüvenil İdyopatik Artrit Tedavisinde Güncel Yaklaşımlar Kenan BARUT Elif KILIÇ KÖNT Özgür KASAPÇOPUR Sistemik Lupus Eritematozusda Güncel Tedavi Hamide Kart KÖSEOĞLU Sjögren Sendromunda Güncel Tedavi Yaklaşımları Pınar TALU ERTEN Antifosfolipid Sendromu Tedavisi Pınar AKYÜZ DAĞLI Ahmet OMMA Gebelikte Sistemik Lupus Eritematozus ve Antifosfolipid Antikor Sendromu: Güncel Tedavi Senar ŞAN Ayten YAZICI Kutanöz Lupus Eritematosus: Güncel Tedavisi Tuğba TEHÇİ Sistemik Skleroz Tedavisi Yasemin YALÇINKAYA Raynaud Fenomeninin Güncel Tedavisi Duygu TEMİZ KARADAĞ İdiopatik İnflamatuar Myopati Güncel Tedavi Figen TARHAN Anti-Sentetaz Sendromu Emel GÖNÜLLÜ Mix Konnektif Doku Hastalığında Güncel Tedavi İpek TÜRK Undiferansiye Bağ Dokusu Hastalığı ve Overlap Sendromlar Güncel Tedavi Derya KAŞKARİ Poliarteritis Nodosa Güncel Tedavisi Esra KAYACAN ERDOĞAN Dev Hücreli Arterit ve Polimyaljiya Romatika Tedavisi Vedat GERDAN Granülomatöz Polianjiitis’te Güncel Tedavi Özlem DOĞAN AĞBUGA Diğer Anca İlişkili Vaskülitlerde Güncel Tedavi Emrah KOÇ Takayasu Arteriti Güncel Tedavisi Sema KAYMAZ TAHRA Fatma ALİBAZ ÖNER Klinik Tutulumlara Göre Behçet Hastalığında Güncel Tedavi Yüksel MARAŞ Kawasaki Hastalığı Güncel Tedavi Rabia Miray KIŞLA EKİNCİ İmmun Kompleks Küçük Damar Vaskülitlerinde Güncel Tedavi Elif EDİBOĞLU Sarkoidoz: Güncel Tedavi Müge AYDIN TUFAN Relapsing Polikondrit Suade Özlem BADAK IgG4 İlişkili Hastalık: Güncel Tedavi Nazife Şule YAŞAR BİLGE Timuçin KAŞİFOĞLU Ailevi Akdeniz Ateşi: Güncel Tedavi Zeynep TOKER DİNÇER Serdal UĞURLU Henoch Schönlein Purpurası (HSP) Özge Altuğ GÜCENMEZ FMF Dışı Otoenflamatuar Hastalıklar: Güncel Tedavi Amra ADROVİÇ Mehmet YILDIZ Özgür KASAPÇOPUR Otoinflamatuar Hastalıklarda Aa Amiloidoz Güncel Tedavi Safiye BAKKALGerçek CAN Gut: Güncel Tedavi Gezmiş KİMYON CPPD Güncel Tedavi Fatih Necip ARICI Alper YILDIRIM Konnektif Doku Hastalığı İlişkili Pulmoner Arteriyel Hipertansiyon Tedavisi Alper SARI Romatolojik Hastalıklarda İnterstisyel Akciğer Hastalığı: Güncel Tedavi Zevcet YILMAZ Romatolojik Hastalıklarda Aşılama Mehmet Ali AŞIK Gebe, Emziren Ve Gebelik Planı Olan Romatoloji Hastalarında Paternal ve Maternal İlaç Kullanımı Sercan GÜCENMEZ

  • Open Access

    Frequency of fibromyalgianess in patients with rheumatoid arthritis and ankylosing spondylitis: A multicenter study of Turkish League Against Rheumatism (TLAR) network

    by Fikriye Figen Ayhan, Ayşen Akıncı, İlKer Ünal, Ömer Faruk Şendur, Elif Aydın, Esra Gizem Koyuncu, Nurettin Taştekin, Akın Erdal, Ülkü Uçar, Taciser Kaya, et al.

    Objectives: This study aimed to evaluate the frequency of fibromyalgianess, fibromyalgia syndrome (FS), and widespread pain in patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and their relationship with clinical and demographic parameters. Patients and methods: This cross-sectional multicenter trial was performed in 14 centers across Türkiye between June 2018 and November 2019. Out of 685 patients recruited from the accessible population, 661 patients (342 RA, 319 AS; 264 males, 397 females; mean age: 48.1±12.9 years; range, 17 to 88 years) met the selection criteria. In these cohorts, those who did not meet the criteria for FS and had widespread pain (widespread pain index ≥7) were evaluated as a separate group. Clinical status and demographic parameters of patients in both cohorts were evaluated as well as the evaluations of RA and AS patients with widespread pain (widespread pain index ≥7) and RA and AS patients with FS groups. In addition, correlations between polysymptomatic distress scale (PSD) scores and Visual Analog Scale (VAS), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and Disease Activity Score using 28 joint counts for RA patients and VAS, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Ankylosing Spondylitis Disease Activity Score (ASDAS) for AS patients were analyzed. Results: Frequencies of patients with FS and patients who had PSD scores ≥12 were 34.1% and 44.4% in all RA patients, respectively. Moreover, FS and PSD scores ≥12 were found in 29.2% and 36.9% of all AS patients, respectively. PSD scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. SDAI and CDAI scores of RA patients with FS were higher than all RA patients and RA patients with widespread pain. Similarly, PSD scores of AS patients with FS were higher than all AS patients and AS patients with widespread pain. ASDAS-erythrocyte sedimentation rate and BASDAI scores of AS patients with FS were found higher than all AS patients and AS patients with widespread pain. Conclusion: Disease activity scores, including pain in RA and AS, were higher in the presence of FS or fibromyalgianess. It may be related to clinical parameters, but cohort studies with long-term follow-up are needed to reveal causality. Additionally, to avoid overtreatment, coexistence of fibromyalgianess should be kept in mind in patients who have inflammatory diseases such as RA and AS, particularly with intractable widespread pain.


  • Familial Mediterranean fever: perspective on female fertility and disease course in pregnancy from a multicenter nationwide network

    by Fatma Gül Yurdakul, Hatice Bodur, Hasan Fatih Çay, Ülkü Uçar, Yaşar Keskin, Betül Sargın, Gülcan Gürer, Ozan Volkan Yurdakul, Mustafa Çalış, Hülya Deveci, et al.

    The aim of this study was to analyze the pregnancy process, especially the Familial Mediterranean fever (FMF) disease course and attack types during pregnancy, and to examine the relationship between disease-related factors and female infertility in FMF patients. The study, which was planned in a multicenter national network, included 643 female patients. 435 female patients who had regular sexual intercourse were questioned in terms of infertility. Pregnancy and delivery history, FMF disease severity and course during pregnancy were evaluated. The relationship between demographic and clinical findings, disease severity, genetic analysis results and infertility was investigated. 401 patients had at least 1 pregnancy and 34 patients were diagnosed with infertility. 154 patients had an attack during pregnancy. 61.6% of them reported that attacks during pregnancy were similar to those when they were not pregnant. The most common attack symptoms were fever, fatigue and abdominal pain-peritonitis (96%, 87%, and 83%, respectively) in the pregnancy period. The disease-onset age, disease activity score, gene mutation analyses, and regular colchicine use (> 90%) were similar between the fertile and infertile groups, while the frequency of previous appendectomy and alcohol consumption rates were higher in individuals with infertility. Our results indicated no significant change in the frequency and severity of attacks during pregnancy. The low rate of infertility (7.8%) in our patients was noted. It has been suggested that the risk of FMF-related infertility may not be as high as thought in patients who are followed up regularly and received colchicine.


  • Evaluation of Sexual Dysfunction in Hospitalized Post-Stroke Rehabilitation Patients

    by Ali Nail Demi̇r, Sanem Aslıhan AYKAN, Uğur Güngör Demi̇r, Hakan Tunç

    Introduction: Stroke-related factors seem to have significant effects on sexual functions in physical, biological, and psychosocial areas. This study aims to evaluate the factors affecting the sexual functions of patients after stroke. Material- methods: This study consisted of 51 (53.1%) male and 45 (46.9%) female patients. Socio -demographics and clinical features of the patients were documented. Sexual functions evaluated with Arizona Sexual Experiences Scale (ASES), International Index of Erectile function (IIEF) and Female Sexual Function Index (FSFI). Results: The mean age of men and women were 57.76±7.57, and 60.13±12.71 years, respectively. When the ASES cut-off point was 11, we found that 88.5% of the participants (84.3% in men and 93.3% in women) had sexual dysfunction. There was no significant difference between the frequency of sexual dysfunction in women and men (p=0.166, Pearson Chi-square Test). According to univariate ANOVA results, age (p=0.028) and BDI (p